P
eer reviewed publications are neces-
sary for dissemination of research
and scholarship. No discipline can thrive
without creating new knowledge to solve
existing or emerging challenges. All
healthcare professions must strive to im-
prove the health and wellness of our soci-
ety, and pharmacists play a crucial role in
enhancing the quality of pharmacothera-
py. We improve outcomes through re
-
search, education, and patient care, and
our experiences are shared with the glob-
al community primarily through peer re-
viewed research papers, review articles,
and case reports.
I wrote my first research article for publication during
the completion of a clinical pharmacy residency in 1977.
Having w
ritten a thesis for my undergraduate pharmacy de-
gree and then for MS and PharmD degrees under the guid-
ance of academic advisors gave me some confidence in writ-
ing, and the critical comments of my residency director on
the drafts of the article were important in having it accepted
for publication. I have also had opportunities to serve as a ref
-
eree for articles submitted to various journals and as an editor
for making decisions about acceptance or rejection of articles
for publication. Through this editorial, I hope to share some
of my experiences and provide some tips about writing arti
-
cles for publication in peer reviewed journals, especially
The
Annals
. Although the content may appear self-evident to ex-
perienced authors, it should be useful for newer writers.
Why Bother to Publish an Article?
My motivation to write articles for publication has al
-
ways been the belief that they will contribute to existing
knowledge and thus improve patient care. The principal
reason for many is the desire to share information about
which they are passionate. Sustained contributions to the
literature also bring recognition to an individual and thus
help advance one’s career. A publication record is a key in
receiving competitive grant funding and promotions and
establishing one’
s reputation in the field. Published experts
may also be more likely to be appointed to prestigious na
-
tional committees and elected to national offices than are
those who have not published. These experiences enrich
professional development and can further strengthen the
standing of the individuals within the discipline. One rea-
son for this recognition is that published authors have de-
fended their arguments through peer reviews and have re-
ceived the endorsement of other authors and experts in the
field.
What is the Key to Successful Writing?
Knowledge of the subject is essential, but the critical re
-
quirements to become a published author are strong inter-
est or passion; drive and commitment; the ability to work
effectively with, and learn from, experienced authors; and
Tips for Writing and Publishing an Article
Milap C Nahata
Author information provided at the end of the text.
The Annals of Pharmacotherapy
n
2008 February, Volume 42
n
273
www.theannals.com
Peer reviewed publications are the primary source of important new information.
This editorial provides tips for writing various sections of research papers, review
articles, and case reports. Additional topics discussed include making decisions
about authorship, selecting a journal for submission of an article, understanding
the peer review process and expectations of editors and reviewers, and revising
the article. Successful authors combine appropriate knowledge and experience,
personal attributes, and effective collaborations to produce insightful and
important contributions to the literature.
KEY WORDS: authorship, peer review, publication.
Ann Pharmacother
2008;42:273-7.
Published Online, 22 Jan 2008,
www.theannals.com
, DOI 10.1345/aph.1K616
persistence. One must also write frequently and regularly
(eg, every few weeks) rather than making one concentrated
effort during each year.
What do Editors and Reviewers Expect?
Regardless of the type of article, authors must clearly
justify the need for its publication.
The Annalssubmis-
sions are reviewed for clinical significance, originality or
uniqueness, accuracy, reproducibility, timeliness, quality,
clarity, and conciseness. The most important questions to
ask before you begin writing are, “What would this article
add to existing knowledge in the literature?”; “How signif-
icant is the message being conveyed by the article to im-
prove the understanding of pharmacotherapy?”; and “How
would this information change patient care?”
Deciding on Authorship
The article’s list of authors and the order in which they ap-
pear should be decided based on relative contributions to the
work, not politics. Most peer reviewed journals, including
The Annals, follow the Uniform Requirements for
Manuscripts Submitted to Biomedical Journals
(www.icmje.
org) for authorship. As described in our Author Guidelines,
authorship is based on the contributions made by authors
to project conception/design; collection, analysis, and/or
interpretation of data; drafting or revision of the article;
and approval of the final version. The person listed first is
considered the primary or lead author and has generally
done more work than the other authors. The corresponding
author is often the senior author (eg, preceptor or program
director), who usually submits the article to the journal, re-
ceives correspondence from the editor, and is responsible
for revision of the article and correction of galley proofs.
The corresponding author is often listed either last or sec-
ond among all authors.
It is critical to decide authorships and specific contribu
-
tions that each author will make to the project or article be-
fore initiating the work. This does not seem to happen in
many cases because it may be uncomfortable to discuss this
issue, but it will be just as uncomfortable at the end of the
writing process as it is at the beginning. An initial discussion
about authorship should also clarify responsibilities so that
the lead and senior authors can hold colleagues accountable.
Failure to address this issue when the team starts work can
result in unjustifiably listing some collaborators as authors,
while others may not be listed when they should have been.
Although most collaborations are positive experiences, I
have heard a few arguments such as, “You list me in your pa-
per, and I will list you in mine,” “Let’s have a rotating author-
ship order
,” “I need it more than you until I am tenured or
promoted,” “I deserve it because these were my patients,” “I
am the director,” or “I am the principal investigator on the
project,” even though the individual did not meet the require-
ments for authorship of the specific article. Support of certain
individuals who have assisted, but do not meet authorship re-
quirements, can be acknowledged in the report without them
being listed as authors.
Preparing an Outline
Once a topic has been selected, the first step should be
to prepare an outline of sections and subsections of the ar-
ticle. This should be done in consultation with an experi-
enced author and is extremely helpful in defining the arti-
cle’s scope and focus and organizing the content. Experi-
enced authors can envision the finished article before they
begin writing it, and this serves as a guide to new writers.
Writing an Introduction
In this section, The Annals expects you to clearly pre-
sent the rationale and justification for the study to improve
patient care. In 12 pages, you must answer questions such
as why the subject is important, what has been done in key
published studies or articles, what the gaps are in current
knowledge, what your rationale was for undertaking this
project, and what your specific objectives were for the
study or article. A hypothesis should be presented for a re-
search study. Similarly, the need for a review article or a
case report, given what has already been published in the
area, should be articulated in this section. Failure to do so
leads one to assume that this is just a “me, too” article, and
this dampens the enthusiasm of a reviewer and editor.
Writing Methods, Results, and Discussion
Sections of a Research Article
A basic principle of science is that findings must not be
due to chance and should be reproducible. This requires a
complete description of the methodology
, types of patients
enrolled, tests, procedures, interventions, analyses, and
outcomes used in the study. Common major problems of a
research papers Methods section are: it is incomplete,
sample size (number of patients or observations) is too
small, accuracy and precision (reproducibility) of mea-
surements are not documented, methods or tests used for
data collection or analyses are unclear or inappropriate,
and definitions of outcomes (eg, cure, improvement, fail
-
ure) are vague. Special mention is needed regarding the
sample size. Reviewers expect that the researcher has in-
cluded a power estimate to increase the likelihood that sta
-
tistically significant findings will result from the study.
Also, observational studies that use existing databases
should adjust for treatment selection. Of course, institu-
tional review board (IRB) approval of the project should
be documented.
274
n
The Annals of Pharmacotherapy
n
2008 February, Volume 42
www
.theannals.com
MC Nahata
The Results section may suffer from incomplete or in-
a
ppropriate presentation of all relevant data and incorrect
attributions or correlations of data. If the lead or senior au-
thors do not have a statistical background, a statistician
must have been consulted for both design and analysis of
data. Tables and figures are often more effective than a
long text narrative to present certain data, and duplication
between data presented in text and tables/figures should be
minimized. Statistical testing of significance such as p val-
ues, confidence intervals, odds or hazard ratios, or relative
risks should be included as appropriate.
In the Discussion section, one should not present results
again, but rather interpret the results, compare the data
with those in previous studies, highlight the clinical signifi-
cance of the results, and reach defendable conclusion(s).
However, reviewers will not be impressed if the authors
over-interpret the data and fail to consider the study limita-
tions. Finally, the authors should briefly indicate what fu-
ture studies may be undertaken to advance the knowledge
in the area.
Writing a Review Article
One must decide the scope of a review article, such as
“treatment of hypertension” versus “treatment of hyperten-
sion with angiotensin-converting enzyme inhibitors in pa-
tients with type 2 diabetes.” The authors must also ask
questions including, “Why is a review article needed?”;
“How will this review article be unique in comparison
with other published articles?”; and “Would you, along
with coauthors, be able to critically review and interpret
the literature and apply current knowledge to patient
care?” Criteria in selecting articles for review, such as re-
search studies alone or research studies plus meta-analy-
ses, should be clearly explained; the inclusion of case se-
ries or case reports should be justified. After collection of
the literature, I suggest thoroughly reviewing each article,
highlighting the key findings with a yellow marker or un-
derlining, interpreting the results, and then writing a brief
paragraph about its impact on practice.
The next important step before writing the text should
be to prepare table(s) of existing studies. Preparing tables
before writing the text allows for an overview of the exist-
ing literature. Tables should include demographic data on
patients, sample size, study design, drug regimens, concur
-
rent drugs and diseases, and efficacy and safety outcomes
data along with p values or confidence intervals. The text
should complement tables by interpreting the data and
highlighting the main findings; trends observed; strengths,
weaknesses, and dif
ferences among studies; and their im
-
pact on patient care. The text should be divided into sec-
tions to improve readability and comprehension. For ex-
ample, an article on a new drug may have sections on in-
troduction, data sources, pharmacology, pharmacokinetics,
clinical trials, adverse effects, drug interactions, precau-
tions and contraindications, dosage and administration,
cost, and summary. Limitations of the literature should be
discussed.
Writing a Case Report
A case report should present a new, unique, or unusual
observation in one or a few patients. The term “case se-
ries” is used when a group or series of patients who had re-
ceived similar treatment are being reported in an article
with detailed information on each patient. It should present
both subjective and objective data about the patients and
events of the clinical courses. The Naranjo scale for assess-
ing an adverse event or the Drug Interaction Probability
Scale (DIPS) for assessing a drug– drug interaction should
be applied as appropriate to ascertain the causality between
the drug and clinical outcome. Approval from the IRB
should be sought if required by the institution (our medical
center requires an approval for a case report because of the
obvious Health Insurance Portability and Accountability
Act concerns).
The Methods and Results sections that appear in a re-
search article are combined and presented under the head-
ing Case Report for this type of article. This section pro-
vides a chronologic account of relevant details of events
and outcomes that occurred in a patient. A table or a figure
may be used to effectively present the course of events.
The Discussion section of a case report is similar to that of
a research article.
Listing of References
The Uniform Requirements for Manuscripts Submitted
to Biomedical Journals
is a set of style and referencing
standards used by most healthcare-related journals, includ-
ing The Annals, as a basis for for
matting reference lists.
Common problems encountered with references include
the following: important studies may have been excluded
or unnecessary studies may have been included, recent ref
-
erences are not incorporated, references are incorrectly cit-
ed within the text or in the reference list itself, the Discus-
sion section is unclear about which results are attributed to
each reference, and primary references are not cited for
factual statements or specific data. As an example, a review
article may be cited for general background about a disease;
however
, primary references should be cited for statements
comparing efficacy rates of 2 drugs to treat a disease. Refer-
ences cited in tables and figures should also be cited in the
text. “Citing Medicine” is a free online guide published by
the National Library of Medicine for citing published print
documents (eg, jour
nals, books, conference publications, sci
-
entific and technical reports, dissertations and theses, patents,
newspaper articles), unpublished material (eg, “in press”
Tips for Writing and Publishing an Article
The Annals of Pharmacotherapy
n
2008 February, Volume 42
n
275
www
.theannals.com
publications, papers and posters presented at meetings, per-
sonal communications), audio and visual media, and material
on CD -ROM, DVD or disk and the Internet (www.ncbi.nlm.
nih.gov/citingmedicine). The search of references should be
repeated prior to submission of an article and throughout the
manuscript review and revision period to ensure inclusion of
all relevant literature. Authors have the responsibility to en-
sure the accuracy of content of all cited references.
Writing an Abstract
The 2 most common problems I have encountered with
abstracts are: they can be too brief and not present a com-
plete, balanced picture of the article; and the data or claims
can be inconsistent with those presented in the text of the
article. Those first encountering the article usually read the
abstract and then decide whether to read the full article
and/or use it in their own work or manuscript. In a research
article, the Methods and Results sections of an abstract
should comprise the majority of the material. In a review
article, the Data Synthesis portion of the abstract requires
more space than other sections to highlight the critical
analysis and interpretation of the literature. I am often sur-
prised to see that the Conclusions section of an abstract is
larger than its Results or Data Synthesis sections. Finally,
one must always confirm the consistency of data presented
in the abstract, text, tables, and figures. I prefer to write an
abstract after the article itself has been written.
Writing a Letter
If one can briefly describe an observation in a patient,
the results of a pilot study, or comment on an important
professional, scientific, or regulatory issue related to phar
-
macotherapy in up to about 2 pages, an authors findings
may be published as a letter
. A letter may also be written in
response to a recently published article in
The Annals if
doing so would add a substantive comment. If the subject
is extensive, it may be considered for publication as a
longer commentary or a special article. The Naranjo and
DIPS probability scales should be used to describe an ad-
verse event and drug interaction, respectively.
Critically Reviewing, Revising, and Reflecting
The quality of all articles can be improved after critical
internal review by coauthors and others. Being “critical” is
the key; you need individuals who can set aside their study
involvement and ask tough questions to improve the paper.
Some authors have a tendency to submit an article prema
-
turely
, which generally leads to rejection by a jour
nal. In
instances where a revision is required, the authors should
address all questions from inter
nal reviews and highlight
changes in the revised manuscript. After being completely
satisfied with the article, authors should reflect on it for
7–10 days, revise the article again, and address responses
to reviewers as needed. They are likely to find additional
ways to enhance the quality and clarity of the article before
journal submission.
Choosing a Journal
There are many choices when deciding where to submit
an article for publication. Important questions to consider
are: Is the journal peer reviewed? Is it indexed in MED-
LINE? Who needs to read the article to change practice
(eg, if pharmacists need to read the article, select a phar-
macy journal; if the article would benefit cardiologists,
choose a cardiology journal)? Is the journal a good match
for your article? Has the journal published related articles?
How long does it take to get an article published by the
journal? Is the journal well respected in its field? Unless
the journal is readily accessible via common search tools
such as MEDLINE or Google, the article will not be as ac-
cessible to others for use and future citations. Consulting
senior colleagues and coauthors can be helpful, and per-
sonnel at
The Annals can also address certain questions.
Publication in a peer reviewed journal is critical, as you
will receive comments from expert reviewers or referees
and have an opportunity to improve the quality of the arti-
cle. Peer reviewed articles are given more credence after
publication. My articles have always benefited from the
peer review process.
One objective criterion used to assess the quality of a
journal is its impact factor. The most recent impact factors
available for jour
nals are for 2006. These were calculated
by dividing the total number of citations to articles pub-
lished in the journal during 2004 and 2005 by the total
number of articles published by the journal during the
same 2 year period. The higher the number, the better it is
(the impact factor for
The Annals was 1.87 in 2005 com
-
pared with 2.27 in 2006). Impact factors have important
limitations, including the fact that a journal’s impact factor
alone does not directly indicate the value of a specific pub-
lished article. However, since promotion and tenure pro-
cess and grant application reviews may consider impact
factors in their evaluations, authors should consider such
factors when selecting a jour
nal for publication. Choosing
a specific journal early in the preparation of an article is
helpful in adapting it to that jour
nal’
s for
mat.
Preparing a T
itle Page
Most journals require that the Title Page include a title,
authors, affiliations, sources of support, conflicts of inter-
est, running head (shorter version of a title), key words,
word counts, and contact information about the corre-
sponding author. The title and key words must be chosen
276
n
The Annals of Pharmacotherapy
n
2008 February, Volume 42
www
.theannals.com
MC Nahata
carefully so that the article can be identified by searches
through PubMed, MEDLINE, or Google. If an article is
not identified in a literature search, it will not be read, used,
or cited by others.
Submitting to the Journal
A common problem we have encountered at The Annals
is that authors do not always follow the Author Guidelines.
Authors should make certain that the article has been pre-
pared in conformance with the journal’s requirements and
ethical standards. A brief cover letter should be included
with the submission highlighting the importance of the
work, ensuring that the article has not been submitted else-
where, and stating that all authors have approved the arti-
cle. A copyright transfer form signed by all authors must
also be submitted.
The Annals prefers to receive all sub
-
missions electronically via its Web site except for the
copyright transfer form.
The Review Process for Articles
Each article is first reviewed internally by The Annals’
editors; those of sufficient quality are subsequently sent to
3 4 exter
nal referees. This process usually takes about a
month and is the basis for making a decision to either ac-
cept the article pending revision or to reject it. In either sit-
uation, after external review, the corresponding author re-
ceives the comments from referees and the editor. When a
revision is required, we request a revised manuscript with-
in a few weeks so that the article can be published in a
timely manner.
Revising the Article
Some comments from referees can be difficult to ad-
dress, but all issues should be taken constructively by the
authors. Here, the advice and support of more experienced
authors or colleagues can be invaluable to put the reviews
in context. The manuscript should be revised to address
referee comments, and authors should provide an explana
-
tion of how these issues were incorporated, including any
disagreement with reviewers. It is important to be respect
-
ful of reviewers, as they invest their time voluntarily, and
generally with significant commitment. They share our
goal to publish the highest quality manuscripts to influence
pharmacotherapy and to reflect favorably on both the au-
thors and the journal.
Proofreading and Updating the Galley
After the revised article has been accepted and edited,
the galley proof (edited document) is sent electronically to
the corresponding author; however, all authors should re-
view the galley and provide comments or corrections to
the corresponding author. The galley text is exactly what
the article will say when published, so all corrections need
to be made by the authors at this stage. It is important to
carefully review these documents, including the text, ta-
bles, figures, and reference citations, and answer all ques
-
tions raised by the editor. Changes made by the manuscript
editor to correct errors or enhance clarity should be accept-
able to authors as long as the meaning of original wording
is unchanged. Extensive changes to the article should not
be made by the authors at this stage; however, any impor-
tant new data published since acceptance of the article
should be added to ensure publication of the most up-to-
date article possible. These final changes should be made
by the authors in a timely manner so that the article can be
finalized and published expeditiously.
In summary, peer reviewed publications are essential for
dissemination of important information through research
papers, review articles, and case reports to improve patient
care. Motivated clinicians have been successful authors
through their personal commitment, ef
fective collabora-
tion, and attention to various steps involved in the publica-
tion process. Each subsequent publication will provide
confidence and professional rewards. We invite you to
consider
The Annals for submission of your manuscripts.
Milap C Nahata MS PharmD, Editor-in-Chief,
The Annals
; Profes-
sor and Division Chair, Pharmacy Practice and Administration, Col-
lege of Pharmacy, and Professor of Internal Medicine and Pediatrics,
College of Medicine, The Ohio State University, 500 W. 12th Ave.,
Columbus, OH 43210, fax 614/292-1335.
Reprints: Dr. Nahata
Tips for Writing and Publishing an Article
The Annals of Pharmacotherapy
n
2008 February, Volume 42
n
277
www
.theannals.com